高级检索
当前位置: 首页 > 详情页

Hospital type and clinical outcomes in peritoneal dialysis: Findings from the PDTAP study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Peking Univ First Hosp, Dept Med, Renal Div, Beijing, Peoples R China [2]Peking Univ, Inst Nephrol, Beijing, Peoples R China [3]Minist Educ, Minist Hlth, Key Lab Renal Dis, Beijing, Peoples R China [4]Peking Univ, Key Lab Chron Kidney Dis Prevent & Treatment, Minist Educ, Beijing, Peoples R China [5]Chinese Acad Med Sci, Res Units Diag & Treatment Immune mediated Kidney, Beijing, Peoples R China [6]Beijing Miyun Dist Hosp, Dept Med, Renal Div, Beijing, Peoples R China [7]Hebei Med Univ, Hosp 2, Dept Med, Renal Div, Shijiazhuang, Peoples R China [8]Army Med Univ, Mil Med Univ 3, Dept Nephrol, Xinqiao Hosp,Chongqing Clin Res Ctr Kidney & Urol, Chongqing, Peoples R China [9]Peking Univ, Shenzhen Hosp, Dept Med, Renal Div, Shenzhen, Guangdong, Peoples R China [10]Hebei Med Univ, Hosp 3, Dept Med, Renal Div, Shijiazhuang, Peoples R China [11]Peoples Hosp Qinghai Prov, Dept Med, Renal Div, Qinghai, Peoples R China [12]Handan Cent Hosp, Dept Med, Renal Div, Handan, Hebei, Peoples R China [13]Peking Haidian Hosp, Dept Med, Renal Div, Beijing, Peoples R China [14]China Med Univ, Shengjing Hosp, Dept Nephrol, Shenyang, Liaoning, Peoples R China [15]Cangzhou Cent Hosp, Dept Med, Renal Div, Cangzhou, Hebei, Peoples R China [16]Anhui Med Univ, Affiliated Hosp 2, Dept Med, Renal Div, Hefei, Peoples R China [17]Zhengzhou Univ, Affiliated Hosp 1, Dept Med, Renal Div, Zhengzhou, Henan, Peoples R China [18]Harbin Med Univ, Affiliated Hosp 2, Dept Med, Renal Div, Harbin, Heilongjiang, Peoples R China [19]BaoTou Med Coll, Affiliated Hosp 1, Dept Med, Renal Div, Neimenggu, Peoples R China [20]Peoples Hosp Langfang, Dept Med, Renal Div, Langfang, Hebei, Peoples R China [21]Peoples Hosp Gansu, Dept Med, Renal Div, Longnan, Gansu, Peoples R China [22]Peking Univ, Peoples Hosp, Dept Med, Renal Div, Beijing, Peoples R China [23]Pingdingshan First Peoples Hosp, Dept Med, Renal Div, Pingdingshan, Henan, Peoples R China [24]First Peoples Hosp Xining, Dept Med, Renal Div, Xining, Qinghai, Peoples R China [25]Taiyuan Cent Hosp, Dept Med, Renal Div, Taiyuan, Shanxi, Peoples R China [26]Cangzhou Peoples Hosp, Dept Med, Renal Div, Cangzhou, Hebei, Peoples R China [27]First Hosp Jilin Univ, Dept Med, Renal Div, Jilin, Peoples R China [28]Peoples Hosp Chuxiong Yi Autonomous Prefecture, Dept Med, Renal Div, Chuxiong, Yunnan, Peoples R China [29]Shanxi Med Univ, Hosp 2, Dept Med, Renal Div, Taiyuan, Peoples R China [30]Beijing Boai Hosp, China Rehabil Res Ctr, Dept Med, Renal Div, Beijing, Peoples R China [31]Beijing Dongzhimen Hosp, Dept Med, Renal Div, Beijing, Peoples R China [32]Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China
出处:
ISSN:

关键词: Health equity hemodialysis transfer hospital type mortality PD-related peritonitis peritoneal dialysis

摘要:
Background There are inequalities in resource allocation and services across peritoneal dialysis (PD) centers in China. This study aimed to explore the association between hospital type (university-affiliated vs. non-university-affiliated hospitals) and clinical outcomes in PD patients. Methods Data from the Peritoneal Dialysis Telemedicine-assisted Platform cohort was analyzed. The primary outcome was all-cause mortality, while secondary outcomes included hemodialysis transfer and first-episode PD-related peritonitis. Univariable and multivariable Fine-Gray models were used to calculate subdistribution hazard ratios (SHRs). Propensity-score matched analyses and sensitivity analyses restricted to incident patients were also performed. Results A total of 7416 PD patients were enrolled (June 2016 to April 2019), with a median follow-up of 29.0 months. University-affiliated hospitals' patients (n = 4806) were younger, had better nutritional status, and higher socio-economic status than those in non-university-affiliated hospitals (n = 2610). University-affiliated hospitals exhibited a lower risk for all-cause mortality (SHR: 0.72, 95% confidence interval (CI): 0.61-0.85, p < 0.001), higher hemodialysis transfer (SHR: 1.31, 95% CI: 1.08-1.60, p < 0.01), but no association with first-episode peritonitis in multivariable analyses. After propensity-score matching, university-affiliated hospitals were still associated with lower all-cause mortality (SHR: 0.74, 95% CI: 0.61-0.91, p < 0.01) and a higher risk of hemodialysis transfer (SHR: 1.52, 95% CI: 1.19-1.94, p < 0.01). Comparable results for all-cause mortality and first-episode peritonitis also found in incident patients. Conclusion In China, PD patients in university-affiliated hospitals had lower mortality but a higher risk of hemodialysis transfer. Further studies are needed to understand these findings and inform future practices and resource allocations.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 泌尿学与肾脏学
JCR分区:
出版当年[2024]版:
Q1 UROLOGY & NEPHROLOGY
最新[2024]版:
Q1 UROLOGY & NEPHROLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Peking Univ First Hosp, Dept Med, Renal Div, Beijing, Peoples R China [2]Peking Univ, Inst Nephrol, Beijing, Peoples R China [3]Minist Educ, Minist Hlth, Key Lab Renal Dis, Beijing, Peoples R China [4]Peking Univ, Key Lab Chron Kidney Dis Prevent & Treatment, Minist Educ, Beijing, Peoples R China [5]Chinese Acad Med Sci, Res Units Diag & Treatment Immune mediated Kidney, Beijing, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Peking Univ First Hosp, Dept Med, Renal Div, Beijing, Peoples R China [2]Peking Univ, Inst Nephrol, Beijing, Peoples R China [3]Minist Educ, Minist Hlth, Key Lab Renal Dis, Beijing, Peoples R China [4]Peking Univ, Key Lab Chron Kidney Dis Prevent & Treatment, Minist Educ, Beijing, Peoples R China [5]Chinese Acad Med Sci, Res Units Diag & Treatment Immune mediated Kidney, Beijing, Peoples R China [*1]Peking Univ First Hosp, Dept Med, Renal Div, 8 Xishiku St, Beijing 100034, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:95756 今日访问量:0 总访问量:832 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号 ICP备案:滇ICP备15003244号